Delivery of cancer therapeutics using nanotechnology
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lim, E.-K. | - |
dc.contributor.author | Jang, E. | - |
dc.contributor.author | Lee, K. | - |
dc.contributor.author | Haam, S. | - |
dc.contributor.author | Huh, Y.-M. | - |
dc.date.accessioned | 2021-09-06T09:45:10Z | - |
dc.date.available | 2021-09-06T09:45:10Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 1999-4923 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/105887 | - |
dc.description.abstract | Nanoparticles have been investigated as drug carriers, because they provide a great opportunity due to their advantageous features: (i) various formulations using organic/inorganic materials, (ii) easy modification of targeting molecules, drugs or other molecules on them, (iii) effective delivery to target sites, resulting in high therapeutic efficacy and (iv) controlling drug release by external/internal stimuli. Because of these features, therapeutic efficacy can be improved and unwanted side effects can be reduced. Theranostic nanoparticles have been developed by incorporating imaging agents in drug carriers as all-in-one system, which makes it possible to diagnose and treat cancer by monitoring drug delivery behavior simultaneously. Recently, stimuli-responsive, activatable nanomaterials are being applied that are capable of producing chemical or physical changes by external stimuli. By using these nanoparticles, multiple tasks can be carried out simultaneously, e.g., early and accurate diagnosis, efficient cataloguing of patient groups of personalized therapy and real-time monitoring of disease progress. In this paper, we describe various types of nanoparticles for drug delivery systems, as well as theranostic systems. © 2013 by the authors; licensee MDPI, Basel, Switzerland. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.subject | camptothecin | - |
dc.subject | caspase | - |
dc.subject | cathepsin B | - |
dc.subject | doxorubicin | - |
dc.subject | gemcitabine | - |
dc.subject | gold nanoparticle | - |
dc.subject | inorganic compound | - |
dc.subject | macrogol | - |
dc.subject | nanocarrier | - |
dc.subject | nanocoating | - |
dc.subject | nanomaterial | - |
dc.subject | nanoparticle | - |
dc.subject | nanosphere | - |
dc.subject | organic compound | - |
dc.subject | polymer | - |
dc.subject | solid lipid nanoparticle | - |
dc.subject | trastuzumab | - |
dc.subject | article | - |
dc.subject | cancer cell | - |
dc.subject | cancer chemotherapy | - |
dc.subject | drug delivery system | - |
dc.subject | drug formulation | - |
dc.subject | drug half life | - |
dc.subject | drug receptor binding | - |
dc.subject | drug solubility | - |
dc.subject | drug stability | - |
dc.subject | drug structure | - |
dc.subject | enzyme activation | - |
dc.subject | gel | - |
dc.subject | human | - |
dc.subject | lipid bilayer | - |
dc.subject | magnetism | - |
dc.subject | nanoencapsulation | - |
dc.subject | nanopharmaceutics | - |
dc.subject | pH measurement | - |
dc.subject | porosity | - |
dc.subject | reticuloendothelial system | - |
dc.subject | surface property | - |
dc.subject | timed drug release | - |
dc.subject | ultrasound | - |
dc.title | Delivery of cancer therapeutics using nanotechnology | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, K. | - |
dc.identifier.doi | 10.3390/pharmaceutics5020294 | - |
dc.identifier.scopusid | 2-s2.0-84877899798 | - |
dc.identifier.bibliographicCitation | Pharmaceutics, v.5, no.2, pp.294 - 317 | - |
dc.relation.isPartOf | Pharmaceutics | - |
dc.citation.title | Pharmaceutics | - |
dc.citation.volume | 5 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 294 | - |
dc.citation.endPage | 317 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | camptothecin | - |
dc.subject.keywordPlus | caspase | - |
dc.subject.keywordPlus | cathepsin B | - |
dc.subject.keywordPlus | doxorubicin | - |
dc.subject.keywordPlus | gemcitabine | - |
dc.subject.keywordPlus | gold nanoparticle | - |
dc.subject.keywordPlus | inorganic compound | - |
dc.subject.keywordPlus | macrogol | - |
dc.subject.keywordPlus | nanocarrier | - |
dc.subject.keywordPlus | nanocoating | - |
dc.subject.keywordPlus | nanomaterial | - |
dc.subject.keywordPlus | nanoparticle | - |
dc.subject.keywordPlus | nanosphere | - |
dc.subject.keywordPlus | organic compound | - |
dc.subject.keywordPlus | polymer | - |
dc.subject.keywordPlus | solid lipid nanoparticle | - |
dc.subject.keywordPlus | trastuzumab | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | cancer cell | - |
dc.subject.keywordPlus | cancer chemotherapy | - |
dc.subject.keywordPlus | drug delivery system | - |
dc.subject.keywordPlus | drug formulation | - |
dc.subject.keywordPlus | drug half life | - |
dc.subject.keywordPlus | drug receptor binding | - |
dc.subject.keywordPlus | drug solubility | - |
dc.subject.keywordPlus | drug stability | - |
dc.subject.keywordPlus | drug structure | - |
dc.subject.keywordPlus | enzyme activation | - |
dc.subject.keywordPlus | gel | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | lipid bilayer | - |
dc.subject.keywordPlus | magnetism | - |
dc.subject.keywordPlus | nanoencapsulation | - |
dc.subject.keywordPlus | nanopharmaceutics | - |
dc.subject.keywordPlus | pH measurement | - |
dc.subject.keywordPlus | porosity | - |
dc.subject.keywordPlus | reticuloendothelial system | - |
dc.subject.keywordPlus | surface property | - |
dc.subject.keywordPlus | timed drug release | - |
dc.subject.keywordPlus | ultrasound | - |
dc.subject.keywordAuthor | Cancer | - |
dc.subject.keywordAuthor | Drug delivery | - |
dc.subject.keywordAuthor | Nanoparticles | - |
dc.subject.keywordAuthor | Nanotechnology | - |
dc.subject.keywordAuthor | Theranostic nanoparticles | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.